Role of macrophages and activated microglia in neuropathic pain associated with chronic progressive spinal cord compression

被引:0
作者
Naoto Takeura
Hideaki Nakajima
Shuji Watanabe
Kazuya Honjoh
Ai Takahashi
Akihiko Matsumine
机构
[1] University of Fukui,Department of Orthopaedics and Rehabilitation Medicine, Faculty of Medical Sciences
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neuropathic pain (NeP) is commonly encountered in patients with diseases associated with spinal cord damage (e.g., spinal cord injury (SCI) and compressive myelopathy). Recent studies described persistent glial activation and neuronal hyperactivity in SCI, but the pathomechanisms of NeP in chronic compression of the spinal cord remains elusive. The purpose of the present study was to determine the roles of microglia and infiltrating macrophages in NeP. The study was conducted in chimeric spinal hyperostotic mice (ttw/ttw), characterized by chronic progressive compression of the spinal cord as a suitable model of human compressive myelopathy. The severity of spinal cord compression correlated with proportion of activated microglia and hematogenous macrophages. Spinal cord compression was associated with overexpression of mitogen-activated protein kinases (MAPKs) in infiltrating macrophages and reversible blood-spinal cord barrier (BSCB) disruption in the dorsal horns. Our results suggested that chronic neuropathic pain in long-term spinal cord compression correlates with infiltrating macrophages, activated microglial cells and the associated damage of BSCB, together with overexpression of p-38 MAPK and p-ERK1/2 in these cells. Our findings are potentially useful for the design of new therapies to alleviate chronic neuropathic pain associated with compressive myelopathy.
引用
收藏
相关论文
共 82 条
[1]  
Treede RD(2008)Neuropathic pain: redefinition and a grading system for clinical and research purposes Neurology. 70 1630-1635
[2]  
Yamashita T(2014)Prevalence of neuropathic pain in cases with chronic pain related to spinal disorders J Orthop Sci. 19 15-21
[3]  
Takahashi K(2006)The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes Diabetes Care. 29 1518-1522
[4]  
Yonenobu K(2008)A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions Pain Pract. 8 45-56
[5]  
Kikuchi S(2009)Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics Diabetes Metab. 35 206-213
[6]  
Davies M(2019)Multicenter cross-sectional study of the clinical features and types of treatment of spinal cord-related pain syndrome Journal of Orthopaedic Science 24 798-804
[7]  
Brophy S(2010)The burden of neuropathic pain: a systematic review and meta-analysis of health utilities Pain. 149 338-344
[8]  
Williams R(2017)The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population Eur J Pain. 21 727-737
[9]  
Taylor A(2018)Microglia in the CNS and Neuropathic Pain Adv Exp Med Biol. 1099 77-91
[10]  
Sadosky A(2019)Role of the P2X4 receptor in neuropathic pain Curr Opin Pharmacol. 47 33-39